CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-05 | Bodenstedt Matthias Chief Financial Officer | Returned to the company | −147,135 | 357,445 | ||
| 2023-04-05 | Bodenstedt Matthias Chief Financial Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −12,212 | 0 | ||
| 2023-04-05 | Bodenstedt Matthias Chief Financial Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −4,374 | 10,626 | ||
| 2023-04-05 | Reich Kristian Chief Scientific Officer | Conversion | +500,006 | 500,006 | ||
| 2023-04-05 | Reich Kristian Chief Scientific Officer | Returned to the company | −500,006 | 2,527,477 | ||
| 2023-04-05 | Reich Kristian Chief Scientific Officer | Conversion | +98,090 | 98,090 | ||
| 2023-04-05 | Reich Kristian Chief Scientific Officer | Returned to the company | −98,090 | 238,297 | ||
| 2023-04-05 | Reich Kristian Chief Scientific Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −14,864 | 75,136 | ||
| 2023-04-05 | Reich Kristian Chief Scientific Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −2,916 | 7,084 | ||
| 2023-03-21 | Chen Bihua 10% owner | Purchase | +238,511 | $21.70 | $5.2M | 3,677,100 |
| 2023-03-20 | Chen Bihua 10% owner | Purchase | +446,881 | $19.36 | $8.7M | 3,296,881 |
| 2023-03-20 | Chen Bihua 10% owner | Purchase | +63,700 | $20.42 | $1.3M | 3,360,581 |
| 2023-03-20 | Chen Bihua 10% owner | Purchase | +78,008 | $21.08 | $1.6M | 3,438,589 |
| 2022-04-06 | Sturge Simon Director | Grant or award · Option to Buy | +45,000 | 45,000 | ||
| 2022-04-06 | Xavier Ramnik Director | Grant or award · Option to Buy | +45,000 | 45,000 | ||
| 2022-04-06 | Moukheibir Catherine Director | Grant or award · Option to Buy | +45,000 | 45,000 | ||
| 2022-04-06 | Phillips Andrew John Director | Grant or award · Option to Buy | +45,000 | 45,000 | ||
| 2022-04-05 | Helix Holdings LLC Former 10% Holder | Conversion | +2,785,000 | 3,215,000 | ||
| 2022-04-05 | Helix Holdings LLC Former 10% Holder | Conversion · Class B Ordinary Shares | −2,785,000 | 0 | ||
| 2022-04-05 | Chen Bihua 10% owner | Conversion | +2,785,000 | 3,215,000 |
Page 9 of 10 · 184 trades